459 related articles for article (PubMed ID: 17355999)
1. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
Chan A; Iannucci A; Dager WE
Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
[TBL] [Abstract][Full Text] [Related]
2. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
Debourdeau P; Chahmi DK; Zammit C; Farge-Bancel D
Pathol Biol (Paris); 2008 Jun; 56(4):211-9. PubMed ID: 18395994
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.
Verso M; Agnelli G
J Clin Oncol; 2003 Oct; 21(19):3665-75. PubMed ID: 14512399
[TBL] [Abstract][Full Text] [Related]
4. The use of low-dose warfarin as prophylaxis for central venous catheter thrombosis in patients with cancer: a meta-analysis.
Rawson KM; Newburn-Cook CV
Oncol Nurs Forum; 2007 Sep; 34(5):1037-43. PubMed ID: 17878131
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients.
Magagnoli M; Masci G; Castagna L; Pedicini V; Poretti D; Morenghi E; Brambilla G; Santoro A
Am J Hematol; 2006 Jan; 81(1):1-4. PubMed ID: 16369969
[TBL] [Abstract][Full Text] [Related]
6. Therapy Insight: venous-catheter-related thrombosis in cancer patients.
Agnelli G; Verso M
Nat Clin Pract Oncol; 2006 Apr; 3(4):214-22. PubMed ID: 16596145
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer.
Revel-Vilk S; Yacobovich J; Tamary H; Goldstein G; Nemet S; Weintraub M; Paltiel O; Kenet G
Cancer; 2010 Sep; 116(17):4197-205. PubMed ID: 20533566
[TBL] [Abstract][Full Text] [Related]
8. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
[TBL] [Abstract][Full Text] [Related]
9. Prevention of central venous catheter-associated thrombosis: a meta-analysis.
Kirkpatrick A; Rathbun S; Whitsett T; Raskob G
Am J Med; 2007 Oct; 120(10):901.e1-13. PubMed ID: 17904462
[TBL] [Abstract][Full Text] [Related]
10. Catheter-related thrombosis in hematologic patients.
Moia M; Cortelezzi A; Falanga A
Rev Clin Exp Hematol; 2004 Jun; 8(1):E5. PubMed ID: 16029971
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.
Akl EA; Karmath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook D; Schünemann HJ
Cochrane Database Syst Rev; 2007 Jul; (3):CD006468. PubMed ID: 17636845
[TBL] [Abstract][Full Text] [Related]
12. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline.
Schiffer CA; Mangu PB; Wade JC; Camp-Sorrell D; Cope DG; El-Rayes BF; Gorman M; Ligibel J; Mansfield P; Levine M
J Clin Oncol; 2013 Apr; 31(10):1357-70. PubMed ID: 23460705
[TBL] [Abstract][Full Text] [Related]
13. [Complications associated with central venous catheters in patient with hematologic neoplasms or hematopoietic transplants].
Gutiérrez AM; Solano C; Gimeno C; García-Conde J
Sangre (Barc); 1999 Jun; 44(3):171-5. PubMed ID: 10481576
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
Mismetti P; Mille D; Laporte S; Charlet V; Buchmüller-Cordier A; Jacquin JP; Fournel P; Dutrey-Dupagne C; Decousus H;
Haematologica; 2003 Jan; 88(1):67-73. PubMed ID: 12551829
[TBL] [Abstract][Full Text] [Related]
15. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
Cunningham RS
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic complications of central venous catheters in cancer patients.
Kuter DJ
Oncologist; 2004; 9(2):207-16. PubMed ID: 15047925
[TBL] [Abstract][Full Text] [Related]
17. Management of thrombosis in the cancer patient.
Andrea N; Ansell J
J Support Oncol; 2003; 1(4):235-8, 240-2; discussion 239-40, 243-5. PubMed ID: 15334865
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.
Klerk CP; Smorenburg SM; Büller HR
Arch Intern Med; 2003 Sep; 163(16):1913-21. PubMed ID: 12963564
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in cystic fibrosis.
Takemoto CM
Pediatr Pulmonol; 2012 Feb; 47(2):105-12. PubMed ID: 22006666
[TBL] [Abstract][Full Text] [Related]
20. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
